Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders
Julia Gallucci(Centre for Addiction and Mental Health), Aristotle N. Voineskos(Centre for Addiction and Mental Health), Lindsay D. Oliver(Centre for Addiction and Mental Health), Erin W. Dickie(Centre for Addiction and Mental Health), Hajer Nakua(Centre for Addiction and Mental Health), Ju‐Chi Yu(Centre for Addiction and Mental Health), George Foussias, Peter Zhukovsky(Harvard University), Daniel M. Blumberger(Centre for Addiction and Mental Health), Colin Hawco(Centre for Addiction and Mental Health), Zafiris J. Daskalakis(University of San Diego)
Cited by 10
Related Papers
Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial
|The Lancet|2018|1.3k
Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group
|Molecular Psychiatry|2017|733
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
|The Canadian Journal of Psychiatry|2016|582
Neuroimaging Evidence for the Deficit Subtype of Schizophrenia
|JAMA Psychiatry|2013|175